Results of Phase III GADOLIN trial for follicular lymphoma
Immunotherapy clinical trial participation in R/R AML
How effective are monoclonal antibodies at improving overall survival?
What is the focus of lymphoma research in 2017?
Personalising treatment to the biology of the NHL patient